skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: What is your opinion on this company.Also is the dividend safe?Seems a little high.Thank You.
Read Answer Asked by glenn on September 23, 2015
Q: Hi Peter and team,

Can you get me an overview on the company. Is the dividend is safe. Is the revenue growing and is it a good time to buy. I am looking for income for long term like 5-10 years. Thanks

Norwood
Read Answer Asked by Norwood on September 23, 2015
Q: I have a fairly large amount of US cash which I need to pay for renovations in Maui in 8 months. I have it sitting in RBC Investment Savings Account series A. Is there anything you might suggest which has a higher yield but still has the option for me to cash out next Spring. Please keep up the great work.
Read Answer Asked by Mike on September 23, 2015
Q: What do you guys think about kinaxis? I know it has a strong balance sheet and no debt. However, is this one of those stocks that are "always expensive"? I am not sure how fragmented the supply management business is and if kinaxis can benefit from it. Are the profit margins good?
Thanks guys keep up the great work!!
Read Answer Asked by Marie on September 23, 2015
Q: Good Evening
Back on July 10, 2015 you indicated that it is worthwhile to hold on Peyto.I noted that one PEYTO Director sold 744,719 shares from September 14th to September 21st, 2015 at between $30.08 and $28.96.
Peyto represents 1% of my portfolio and the oil/gas sector is around 5%.
Do you still recommend on holding to this stock, selling or averaging down?

I will appreciate your comments.
Thank you
Read Answer Asked by Terry on September 23, 2015
Q: I took my holdings percentage up to 3% this morning from 2.5 mainly because I like the long term potential and even with the dividend increase its payout ratio is still low at 40 to 50%. I was able to get in at $34 which is less then the 34.25 share offering. I do not usually average down but with today's add I am in at $37 per share. I firmly believe that this firm is solid but not correctly named. I think it should drop the "gas" as it misleads investors as to the actual holdings it has. Do you view 3% (and its my only holding in this segment)as too high.
Read Answer Asked by James on September 22, 2015
Q: Mr. Buffett has said that he will buy back stock when the share price falls below 1.2x book value. Is the stock nearing those valuations and what do you think of the stock overall?
Read Answer Asked by Eugene on September 22, 2015
Q: Valiant been down large the past few days, what's going on with company. thanks
Read Answer Asked by don on September 22, 2015
Q: Despite the news today regarding reduced outlook, can these stocks be held for the long term . Will they recover?
Thank you.
Read Answer Asked by Francis on September 22, 2015
Q: After selling my business I have a large sum of money to invest - this money is the main part of my retirement savings. I plan to retire in 10 years, so my main objective here is safety of principal with moderate growth to surpass inflation. Inflation is my main concern - with anticipated US growth and CDN stagnation I see it picking up in Canada quite soon. By this very reason I am concerned about investing in bonds (incl. real return ones) or TIPS. What kind of allocation (sector, country, stocks vs. bonds) would you suggest in my case? Any creative solutions to hedge against inflation?
Thanks.
Read Answer Asked by Michael on September 22, 2015
Q: Just ask a question ,,,, seems to be missing some insite on current situation ,,, Sep 21, 2015 (MarketLine Financial Deals Tracker via COMTEX News Network) -- Concordia Healthcare Corp., a Canada-based integrated healthcare company, has filed a preliminary prospectus supplement with the securities regulatory authorities in each of the provinces of Canada and a corresponding registration statement with the US Securities and Exchange Commission (SEC) to issue 8 million common shares in a public offering.
Based on the closing price of Concordia Healthcare's common stock of $72.23 per share on Sep 18, 2015, the transaction is valued at approximately $577.84 million.
Goldman, Sachs & Co., RBC Capital Markets, LLC, Credit Suisse Securities (USA) LLC and Jefferies LLC are acting as book-running managers for the offering.
Deal Value (US$ Million) 577.84
Deal Type IPO
Read Answer Asked by Bob on September 22, 2015
Q: Volkswagen said that they installed software programmed to switch engines to a cleaner mode during official emissions testing. Since Magna makes parts for them, it probably explains why the stock is down 8%. Do you or a member know if Magna develops anything involved with the engine or software that controls it? If not, how about Linamar or MartinRea?
Read Answer Asked by Matt on September 22, 2015
Q: CXR adding 8 million shares to the float. With the apparent 35 per cent accretive to earnings with their new acquisition do you see huge share dilution in earnings per share or a good increase once things get going?
Read Answer Asked by Helen on September 22, 2015
Q: Grateful for your views on these stocks and could you recommend an ETF that would include them ?
Read Answer Asked by Jacques on September 22, 2015
Q: Hi Peter and Ryan,

Can I please get an update on your opinion of Mandalay and Dynacor.

Thanks

Dave
Read Answer Asked by David on September 22, 2015
Q: I am a new investor looking to invest 25K, with a medium risk tolerance. I was hoping you could suggest some stocks to start building a portfolio and advise as to an appropriate % allocation to ensure I get the diversity but also effectively manage risk. Appreciate the guidance and advice!
Read Answer Asked by Michael on September 22, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!